Texas Lawyers Blog

Description

The Texas Lawyers Blog provides useful information on the law and Texas lawyers. For more information on this Blog or a legal topic, please feel free to submit an inquiry or send an e-mail message to blog@texaslawyers.com

Thursday, October 16, 2014

Texas Whistleblower Lawyer: Large Rewards Are Being Offered To Whistleblowers That Expose Significant Fraud

Texas Whistleblower Lawyer: Bounty Actions and Qui Tam Lawsuits Allow Whistleblowers To Collect Large Financial Rewards For Properly Exposing Significant Fraud by Texas Whistleblower Lawyer Jason S. Coomer

Whistleblower Reward Lawsuits are the most effective method for identifying and preventing large scale fraud against the government, in financial markets, and in large corporations.  Through these lawsuits, whistleblowers that properly expose significant fraud can collect large financial rewards.   To date, billions of dollars have been awarded to whistleblowers for exposing significant and hard to detect fraud.  Most of the recoveries to date have been in health care fraud qui tam cases, but new whistleblower bounty actions are increasing in number and one whistleblower recently was award $30 million for exposing significant fraud. This whistleblower was able to protect their identity through the entire process, expose significant fraud, and collect a large reward.

Whistleblower reward lawyer, Jason S. Coomer, works with health care fraud whistleblowers, government contractor and procurement fraud whistleblowers, securities and investment fraud whistleblowers, and FCPA whistleblowers to expose significant fraud and claim whistleblower rewards.  If you are a person with special knowledge of significant fraud practices, please feel free to contact Whistleblower Reward Lawyer Jason Coomer.


Health Care Fraud Whistleblowers including Medicaid Fraud Whistleblowers and Medicare Fraud Whistleblowers Have Helped The Federal and State Governments Recover Billions of Dollars and Have Received Large Financial Rewards For Exposing Health Care Fraud

Health Care Whistleblower Reward Lawsuits have been the most effective method for identifying and preventing large scale health care fraud against the government.  As such, the United States and several states have enacted health care whistleblower reward laws that harness the power of economic incentives by offering large monetary rewards to whistleblowers that properly report significant fraud.  As a health care whistleblower reward lawyer, Jason Coomer works with whistleblowers to confidentially gather information regarding several different types of health care whistleblower rewards including Medicare fraud whistleblower reward lawsuits and Medicaid fraud whistleblower reward lawsuits.

For more information on this area of law, please go to the following web page: Health Care Fraud Whistleblower Reward Lawyer Helps Heath Care Professional Whistleblowers Recover Rewards For Exposing Medicare Fraud, Medicaid Fraud and other Public Health Care Fraud.

Sunday, October 12, 2014

Medical Device Fraud: Large Financial Rewards Are Being Offered to Bio Tech and Medical Device Professionals That Properly Expose Fraud

Medical Device Fraud and Bio Tech Fraud: Large Financial Rewards Are Being Offered to Bio Tech Professionals and Medical Device Professionals That Properly Expose Significant Marketing Fraud by Medical Device Fraud Lawyer Jason Coomer

Large financial rewards are being offered to bio tech professionals and medical device professionals that expose medical device fraud and bio tech fraud.  To receive the large financial reward, the whistleblower must have original information of the marketing fraud and be the first to step forward to properly expose the marketing fraud.  By working with a medical device fraud lawyer, the bio tech professional, medical device professional, or other health care professional can protect their identity while their potential case is reviewed.  For more information on exposing medical device fraud and bio tech fraud, please feel free to contact medical device fraud lawyer Jason Coomer

Also, please feel free to read below or go to the following web pages: Expose Medical Device Marketing Fraud and Expose Off Label Marketing Fraud


Off Label Marketing Fraud, Misinformation Campaigns, and False Study Marketing Schemes Can Be The Basis of FDA Violations and Whistleblower Reward Lawsuits

Off label marketing fraud has been the basis of several large whistleblower reward lawsuits and has resulted in billions of dollars in recoveries and financial rewards.  These schemes have included providing false information to influential health care decision makers, creating false research information to make false claims regarding products, paying influential health care decision makers to promote products, and marketing products for off label purposes under false or misleading representations.

To crack down on marketing fraud, several qui tam lawsuits have been filed against manufacturers that have committed marketing fraud and the FDA has issued new guidelines regarding off label marketing.  These guidelines can be found on the FDA web site.  Additionally, through the Federal False Claims Act and several State Medicaid Fraud Recovery laws, large rewards are being offered to bio tech professionals, pharmaceutical professionals, medical device professionals, and other health care professionals that have original knowledge of significant off label marketing fraud schemes.       



Monday, October 6, 2014

Whistleblower Reward Lawyer: Large Financial Rewards Are Being Offered to Persons That Properly Expose Significant Fraud by Whistleblower Reward Lawyer

Whistleblower Reward Lawyer: Large Financial Rewards Are Being Offered to Persons That Properly Expose Procurement Fraud, Medicare Fraud, Investment Fraud, and Other Forms of Fraud by Whistleblower Reward Lawyer Jason S. Coomer

In our modern society, committing fraud on a mass scale has allowed some banks, hospitals, defense contractors, health care companies, construction companies, investment brokers, hedge fund managers, multinational companies, and other large corporations to become extremely rich.  These fraudulent schemes can often be difficult to detect and often allow these large corporations to get away with millions or billions of dollars.  In fact, it is estimated that over each year large corporations get away with over $2 Trillion in procurement fraud, over $1 Trillion in investment fraud, and over $100 Billion in Medicare/Medicaid fraud.

In response to this massive fraud that has been committed against the United States government, several states, and the American public, the federal government and several states have enacted whistleblower reward laws that offer large financial rewards to individuals and businesses that properly expose fraud and government corruption. Included in many of these laws are whistleblower protections that in some cases allow whistleblowers to anonymously report fraud and corruption through a lawyer.  In other cases there are strong protections against retaliation that provide legal recourse against employers that wrongfully terminate or retaliate against whistleblowers for exposing fraud.

These whistleblower reward laws allow whistleblowers to receive large financial rewards of 10% to 30% of the money that is collected by the government.  To date billions of dollars have been paid to whistleblowers that have properly exposed significant fraud.

For more information on whistleblower reward laws, please go to the following web pages: Whistleblower Reward Lawyer Jason Coomer or Whistleblower Reward Information.

Sunday, September 14, 2014

Hospital Billing Fraud Reward Information: Large Rewards Are Being Offered to Persons That Expose Hospital Billing Fraud by Hospital Billing Fraud Lawyer

Hospital Billing Fraud Reward Information: Large Rewards Are Being Offered To Hospital Administrators, Medical Professionals, and Others Who Properly Expose Hospital Medicare Fraud and Hospital Medicaid Fraud by Hospital Billing Fraud Whistleblower Reward Lawyer Jason Coomer

Hospital Billing Fraud including Illegal Kickbacks, Upcoding, Double Billing, False Coding, and fraudulent mischarging of health care services can be the basis of large whistleblower reward lawsuits that pay large financial rewards to hospital administrators, nurses, medical doctors, and other medical professionals that properly expose the fraud.  These whistleblower reward lawsuits are designed to recover false and fraudulent billing of government benefits including Medicare, Tricare, Medicaid, the Veterans' Administration (VA), and Federal Employees Health Benefits (FEHB) Program.

Medical professionals that step forward to expose significant hospital billing fraud can contact a hospital billing fraud whistleblower reward lawyer to review a potential billing fraud whistleblower reward lawsuit as well as to obtain information on whistleblower rewards and protections that exist under the Federal False Claims Act.

For more information on Hospital Billing Fraud Lawsuits, please feel free to send an e-mail message to hospital billing fraud whistleblower reward lawyer, Jason Coomer, or please feel free to go to the following web pages: Health Care Fraud Whistleblower Reward Lawsuit Information and Hospital Medicare Fraud Whistleblower Reward Lawyer.

To Combat Health Care Fraud Which Is Estimated to Be Over $200 Billion Per Year The United States Is Offering Large Rewards to Persons That Expose Significant Fraud

Health Care Fraud is one of the fastest growing crimes.  It is estimated that health care fraud in the United States has increased to over two hundred billion dollars ($200,000,000,000.00) each year and is continuing to increase each year. Health Care Fraud includes Medicare billing scams and Medicaid billing scams.  Examples of these types of health care fraud include upcoding, double billing, billing for unnecessary services, billing for services not needed, and billing for services not provided. To combat Medicare fraud scams and Medicaid fraud scams, the United States government has amended the Federal False Claims Act to encourage medical professionals to step up and blow the whistle on Medicare fraud and Medicaid fraud. Medicare Fraud Whistleblowers and Medicaid Fraud Whistleblowers that are the original source of specialized knowledge of large health care fraud scam can make substantial recoveries if they are the first to file a successful qui tam claim under the Federal False Claims Act.

Health care administrators, doctors, nurses, and therapists are stepping forward and blowing the whistle on Tricare, the Veterans' Administration (VA), and Medicare billing fraud including manipulation of outlier payments to Medicare, kickbacks, upcoding, or bill padding. These health care professionals are commonly working with a lawyer to make sure that the fraud is properly exposed and to protect their career.


Sunday, September 7, 2014

Expose Stock Fraud Schemes and Earn Large Rewards: New Laws Offer Large Rewards and Allow Anonymous Reporting of Stock Fraud and SEC Violations by Stock Fraud Whistleblower Reward Lawyer

Expose Stock Fraud Schemes and Earn Large Rewards: The SEC Is Offering Large Financial Rewards To Whistleblowers That Anonymously and Properly Expose Stock Fraud Schemes and other SEC Violations by Stock Fraud Whistleblower Reward Lawyer Jason Coomer

The SEC is offering large financial rewards to financial professionals and investors that properly expose stock fraud schemes, insider trading, and other SEC violations.  These rewards are through SEC bounty actions that allow whistleblowers to report fraud anonymously through a lawyer to protect their identity.  These bounty actions and whistleblower protections  have been established to encourage all financial professionals with original knowledge of executive insider trades, hedge fund insider trades, private equity fund fraud, false misleading information on a company's financial statements, false information on Securities and Exchange Commission (SEC) filings, stock manipulation schemes; embezzlement by stockbrokers; and other securities fraud to properly expose the violations.

For more information on anonymously exposing stock fraud schemes and other SEC violations, please go to the following web pages: Expose Insider Trading: Confidential Bounty Action Rewards and Securities Fraud, Commodities Fraud, and Investment Fraud Can Be the Basis of Whistleblower Reward Bounty Actions

Please also feel free to contact or send an e-mail message to Bounty Action Reward Lawyer Jason Coomer.

Confidential Reviews and Anonymous Reporting of Stock Fraud Schemes, Insider Trading, and Investment Fraud Actions Can Protect Financial Professionals and Investors

For many financial professionals and investors, it can be a difficult decision to step forward to expose stock fraud schemes, executive insider trades, hedge fund insider trades, private equity fund fraud, false misleading information on a company's financial statements, false information on Securities and Exchange Commission (SEC) filings, stock manipulation schemes; embezzlement by stockbrokers; and other securities fraud.  To protect these professionals, confidentiality safeguards have been put in place that allow the financial professional whistleblower to blow the whistle on securities fraud through an attorney.  By contacting a Stock Fraud Scheme Whistleblower Reward Lawyer or Investment Fraud Whistleblower Reward Lawyer, the financial professional can protect their identity and career as well as determine if they may have a viable whistleblower reward bounty action.

Saturday, September 6, 2014

Texas Xarelto Fatal Blood Loss Lawyer: Xarelto May Cause Fatal Bleeding and Hemorrhaging by Texas Xarelto Fatal Blood Loss Lawyer

Texas Xarelto Fatal Blood Loss Lawyer: The Blood Thinner, Xarelto, May Cause Excessive Bleeding and Fatal Blood Loss by Texas Xarelto Fatal Blood Loss Lawyer Jason Coomer 

The blood thinner, Xarelto, may cause serious health problems including internal bleeding and hemorrhaging.  This excessive blood loss can be irreversible and may result in death.  Persons taking Xarelto should be aware of the potential danger and discuss the risks and alternatives with their health care provider.

If someone you love has been given Xarelto and has suffered fatal or severe blood loss, it is important that you report the adverse health event to the FDA.  For more information on Xarelto Fatal Blood Loss Lawsuits, please feel free to send an e-mail message to Texas Xarelto Blood Loss Lawyer, Jason Coomer.

Xarelto Internal Bleeding Lawsuit Information

Several Xarelto lawsuits have been filed by families of people that have been given Xarelto and who have lost loved ones as well as individuals that have suffered serious health issues including hemorrhaging.  These lawsuits allege that despite being aware of the significant risk of fatal bleeding and hemorrhaging as well as the fact that there is no know antidote for Xarelto, the manufacturers of the blood thinner, Xarelto, hid this risk from patients and medical providers, while pushing for increased sales of this drug.

The aggressive marketing of the Xarelto is expected to increase sales of Xarelto to over $1 Billion annually in 2014 and to over $3 Billion by 2018.  Several lawsuits for off label marketing of Xarelto are expected to be filed as the use of the drug become more common.

 Xarelto and FDA Warnings

The Federal Food and Drug Administration (FDA) has issued a serious of boxed warnings as well as warnings and precautions regarding the safety of Xarelto.  Some of these warnings are in regard to hemorrhaging dangers that can be caused by Xarelto.

For persons that have been given Xarelto, it is important to seek medical attention, if you develop any signs or symptoms of bleeding such as:
  •     unusual bleeding from the gums
  •     nose bleeding that happens often
  •     menstrual or vaginal bleeding that is heavier than normal
  •     bleeding that is severe or you cannot control
  •     pink or brown urine
  •     red or black stools (looks like tar)
  •     bruises that happen without a known cause or that get larger
  •     coughing up blood or blood clots
  •     vomiting blood or vomit that looks like coffee grounds.
  •     Other symptoms of Pradaxa internal bleeding may include:
  •     Tiredness and Lethargy,  Joint pain or swelling
  •     Headaches Dizziness Weakness
  •     swelling of the arms, hands, feet, ankles or lower legs
If you experience these symptoms or have lost someone that has been given Xarelto, it is important that you report the adverse symptoms or death to your loved ones' health care provider and the FDA.

Friday, September 5, 2014

Fusion Surgery Cancer Risk and Health Alert: Infuse Bone Graft Used in Fusion Surgery May Cause Cancer and Nerve Damage by Texas Fusion Surgery Lawyer

Back and Neck Fusion Surgery Health Alert: The Medtronic Infuse Bone Graft Product That Has Been Used In Thousands of Neck and Back Fusion Surgeries May Cause Cancer, Nerve Damage, and Even Death by Texas Fusion Surgery Lawyer and Texas Fusion Cancer Lawyer Jason S. Coomer  

The bone growth product, Medtronic Infuse Bone Graft, has been used in thousands of fusion surgeries.  Thousands of lawsuits have now been filed that Infuse Bone may cause an increased risk of cancer, nerve damage, or death.  Persons that have had fusion surgery where Infuse has been used should be aware of the potential health risks including cancer danger.  Persons that have been diagnosed with cancer or nerve damage after going through an Infuse Bone Graft Surgery should report the health issues to their physician and the FDA.  Additionally, families that have lost a loved one to cancer, nerve damage, organ failure, or respiratory failure after a fusion surgery should also contact the FDA regarding the death.   

For information regarding a potential Fusion Cancer Lawsuit, Fusion Nerve Damage Lawsuit, or Fusion Death Lawsuit, please feel free to send an e-mail message to Texas Fusion Cancer Lawyer and Texas Fatal Back Fusion Lawyer Jason Coomer. 

FDA Adverse Reports and Post Fusion Surgery Adverse Health Events

Medtronic Infuse Bone Graft is a product that has been commonly used in back fusion surgeries since 2002.  The product contains recombinant human Bone Morphogenetic Protein (rhBMP) which is a genetically engineered protein that initiates bone growth.  The Infuse Bone Graft was approved by the FDA for use in some specific back surgeries, but has not been approved for neck surgery.  The FDA has received more than 200 adverse reports from the Infuse product including patients that have suffered swelling of the neck tissue, which constricted their airways, requiring an emergency tracheotomy, feeding tube, and more surgery.

Persons who have had a back fusion surgery which included the use of Infuse Bone Graft and families of these people should be aware of and report any of the following post surgery adverse health events:

  •     Cancer
  •     Difficulties swallowing, speaking, or breathing
  •     Angioedema (swelling of the neck and throat, which can cause fatal suffocation)
  •     Compression of airway
  •     Impingement of nerves and nerve damage
  •     Unwanted bone growth
  •     Male sterility
  •     Paralysis
  •     Emergency surgery
  •     Disability
  •     Death
Fusion Surgery Cancer Lawsuit, Fatal Fusion Surgery Lawsuit, and Fusion Surgery Nerve Damage Lawsuit Information

For information regarding a potential Fusion Cancer Lawsuit, Fusion Nerve Damage Lawsuit, or Fusion Death Lawsuit, please go to the following web page: Fusion Cancer Lawsuit, Fusion Nerve Damage Lawsuit, or Fusion Death Lawsuit Information.  

Wednesday, September 3, 2014

Large Whistleblower Rewards Are Being Offered to People that Properly Expose Fraud and Corruption

Whistleblowers That Properly Expose Fraud and Corruption Can Receive Large Financial Rewards by Whistleblower Reward Lawyer Jason S. Coomer

The Federal Government and several states have enacted Whistleblower laws that offer large financial rewards to individuals and businesses that properly expose fraud and corruption. Included in many of these laws are whistleblower protections that in some cases allow whistleblowers to anonymously report fraud and corruption through a lawyer, in other cases there are strong protections against retaliation that provide legal recourse against employers that wrongfully terminate whistleblowers for exposing fraud.

For more information on Whistleblower Reward laws and Bounty Action laws, please go to the following web site: Whistleblower Reward Information

Sunday, August 3, 2014

Texas Oil Truck Driver Accident Lawsuit Information: Fatal Oil Truck Accidents Are on The Rise by Texas Oil Truck Driver Accident Lawyer Jason S. Coomer

Texas Oil Truck Driver Accident Lawsuit Information: Many Oil Companies, Trucking Companies, and Oilfield Supply & Equipment Companies Are Ignoring Safety and Causing Texas Oil Truck Driver Fatal Accidents and Serious Injury Accidents by Texas Oil Truck Driver Accident Lawyer Jason S. Coomer

Several oil companies, oilfield related companies, and trucking companies are sacrificing safety to increase profits.  As such, Texas are seeing large oil trucks, pipe trucks, oil drilling mud trucks, and other oil industry trucks speeding down Texas roads by overworked and under trained drivers.  Some of these trucks when they collide with passenger vehicles are causing fatal accidents and catastrophic injury accidents.

Families that have lost a loved one to these vehicles should be aware of several potential causes of action that they have against large corporations and their insurance companies.  These families should also make sure to have a thorough investigation done of the fatal or catastrophic injury accident.  For more information on Truck Wreck Investigations, Texas Oil Truck Driver Accident Lawsuits, and Texas Fatal Accident Causes of Action, please go to the following web pages: The Truck Collision and 18-Wheeler Information and Investigation Center, Texas Oil Truck Driver Accident Lawsuit Information, and Texas Wrongful Death and Survival Actions.

These Fatal Oil Company Truck Accidents Should Be Investigated by Experienced Texas Oil Company Truck Wreck Lawyers to Determine the Cause of The Accident and Prevent Future Similar Accidents

According to the National Center for Statistics and Analysis, thousands of motorists are killed each year by commercial vehicles. Commercial vehicles including oil trucks, oil equipment trucks, and oil supply trucks are too often driven by under trained, inexperienced, and over worked drivers that are under pressure to drive fast as well as keep maintenance costs down.  These factors combined with old roads, country roads, farm roads, heavy traffic, and road construction or potential driver distractions such as cell phones, GPS devices, food, drinks, and texting can cause fatal automobile accidents.

Whether a driver is driving a large commercial vehicle such as a oil pipe truck, oil mud truck, oil equipment truck, company van, oil company 18-wheeler, dump truck, propane truck, garbage truck, construction truck, semi-trucks, tractor-trailer, utility truck, hauling truck, or other commercial vehicle, it is important that the driver be trained to operate the commercial vehicle and have their driving record reviewed for accidents as well as drunk driving convictions.  It is also important that these drivers are not overworked, that their vehicles are safe, and that the companies follow safety rules.  For more information on serious injury and fatal accident investigations, please feel free to contact Texas Oil Truck Driver Accident Lawyer Jason S. Coomer.

Saturday, June 28, 2014

International Drug Company Bribes: Large Financial Rewards Are Being Offered to People That Expose Drug Company Bribes to Public Officials

International Drug Company Bribes: Large Financial Rewards Are Being Offered to People That Expose Drug Company Bribes to Public Officials by International Whistleblower Reward Lawyer Jason S. Coomer

The Foreign Corrupt Practices Act (FCPA) prohibits bribery of foreign officials by U.S. and foreign companies listed on the U.S. securities exchange.  These prohibitions include large drug companies that are paying bribes to doctors, health care administrators, and other government officials to sell drugs and obtain large procurement contracts in China, Russia, and other pharmerging countries. 

Foreign Corrupt Practices Act Whistleblowers that properly report violations of the FCPA by a U.S. or foreign company listed on the U.S. securities exchanges can recover a large reward for exposing FCPA violations.  These whistleblowers can expose bribery schemes through a lawyer and protect their identify. 

For more information on Exposing Drug Company Bribes, please go to the following website: International Whistleblower Rewards

Between $100 Billion to $200 Billion in Corrupt Drug Procurement Contracts Are Obtained Each Year Through Fraud and Corruption

Every year over $4.1 trillion (US dollars) is spent worldwide on health services including approximately $800 billion (US dollars) that is spent in the pharmaceutical market on drugs and medications. It is estimated that approximately 10 to 25% of public health care procurement spending including drug contracts, medicines, pharmaceuticals, medical equipment, and medical devices is lost to corrupt and fraudulent acts.  These acts include government official bribes, illegal kickbacks, and other illicit payment and fraud schemes.

The World Health Organization (WHO) defines the term "medicines chain" to be the steps that are required for the creation, regulation, management and consumption of pharmaceuticals.  In other words it is the medication supply chain in the pharmaceutical industry from creation to end user. According to the World Health Organization, corruption is common in the international pharmaceutical sector and occurs throughout all stages of the medicines supply chain, from research and development to dispensing and promotion.  These unethical and corrupt practices in the medicines supply chain can take many forms such as falsification of evidence, false certification of adulterated drugs, import false certifications, export false certifications, conflicts of interest, and illegal bribe and kickback schemes.

As such, the World Health Organization and many other international public health organizations are seeking public policy changes under the umbrella of good governance initiatives within the medicines chain to reduce government corruption and optimize public health outcomes.  Some proposed public policy changes that can help reduce corruption and fraud in the pharmaceutical medicines chain include: 1) protection of international medicines supply chain whistleblowers; 2) offering financial incentives to international medicines chain whistleblowers; 3) passage of legislation and regulation for drug quality control and official certifications to monitor the transport of medications including the export and import of medicines throughout world and along international medicines supply chains; 4) increased enforcement mechanisms for violations of existing pharmaceutical laws and regulations; and 5) increased resources for conflict of interest management and checks to ensure key people in the medicines chain are not accepting illegal bribes, kickbacks, and other illicit payments.

In response to these good governance initiatives, the international community including the United States, United Kingdom, and many other countries have enacted new anti-bribery and anti corruption laws that will enable persons with knowledge of international medicines supply chain fraud and corruption to expose the illegal acts and reap rewards from blowing the whistle, while being protected from potential retaliation from the wrong doers.

While there are an increasing number of reported cases of corruption in the medicines chain, much unethical practice has historically gone unreported.  This is changing as new whistleblower protections and whistleblower financial incentives are coming into place to help overcome  institutionalized corruption in the pharmaceutical medicines chain and to provide protection for courageous whistleblowers that want to change the institutionalized corruption that is damaging their countries.

Because medicines typically change hands several times in the medicines chain between the drug manufacturer and patients, the large number of steps in the medicines chain allows numerous opportunities for unethical practices to take place.  Therefore increased regulations and laws throughout the medicines chain including manufacturing quality assurances, export regulations and inspections, import regulations and inspections, health care provider regulations and inventory policies, and patient protections are needed.  Fortunately, the new international whistleblower laws will allow international whistleblowers with specialized knowledge of the corruption to blow the whistle on fraud, false certifications, and illicit payments that are occurring throughout the medicines chain.   

A lack of transparency and accountability within the medicines chain can also contribute to unethical practices and corruption.  Therefore increased enforcement mechanisms are needed for violations of existing pharmaceutical laws and regulations.  These enforcement mechanisms include "SEC Bounty Actions" that allow private citizens to work through international medicines supply chain whistleblower reward lawyers to expose significant fraud and obtain large bounties for successful prosecution of pharmaceutical illicit payment schemes.  Ideally, these international medicines supply chain whistleblower reward actions will track fraud and corruption to the root causes and help reform corporate corruption of public health care systems.  Through international pharmaceutical representative whistleblowers, international drug executive whistleblowers, foreign government official whistleblowers, health care provider whistleblowers, and other medicines supply chain whistleblowers, the international community can efficiently identify, expose, and remedy medicines chain corruption.